Jackfruit Effects on Adipokines and Cognition in Boxers
NCT ID: NCT07268976
Last Updated: 2025-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2025-01-07
2025-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Absorption and Antioxidant Effects of Polyphenolics From Acai
NCT02227628
Different Types of Fruits on Metabolic Function and Cognitive Performance
NCT02736331
Sea Buckthorn Aqueous Infusion Impact
NCT07313423
Effect of Cherry Juice on Fat Oxidation and Cardio-metabolic Markers
NCT02999256
ENDOCUR - Modulation of Endotoxaemia Via Curcumin Intake in Healthy Overweight Adults
NCT03329781
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Saliva samples were collected to measure irisin, omentin-1, and BDNF levels. Cognitive performance was assessed using the Wisconsin Card Sorting Test and the Trail Making Test. Anthropometric parameters including weight, BMI, waist, hip, chest, limb circumferences, and body composition were measured at baseline and on day 30.
Statistical analyses were performed using SPSS version 26. ANOVA, Duncan, and Pearson correlation tests were used to determine significant differences and relationships between variables.
This study is randomized and controlled. Participants receive either one of three doses of jackfruit oil extract or no supplement. The follow-up period is 30 days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
J0 - Kontrol Grubu
Katılımcılar hiçbir jackfruit yağı ekstresi almadı. Sadece normal diyet ve antrenman programlarını sürdürdüler.
No interventions assigned to this group
J100
Katılımcılara 100 mg/kg jackfruit yağı ekstresi oral olarak 500 ml su içinde verildi. Müdahale 30 gün boyunca günlük olarak uygulandı.
Jackfruit Supplement
Participants in the experimental group will receive a daily dose of jackfruit supplement during the study period. The supplement is administered orally and standardized for bioactive components. Participants in the control group will not receive any jackfruit supplement.
J200
Katılımcılara 200 mg/kg jackfruit yağı ekstresi oral olarak 500 ml su içinde verildi. Müdahale 30 gün boyunca günlük olarak uygulandı.
Jackfruit Supplement
Participants in the experimental group will receive a daily dose of jackfruit supplement during the study period. The supplement is administered orally and standardized for bioactive components. Participants in the control group will not receive any jackfruit supplement.
J300
Katılımcılara 300 mg/kg jackfruit yağı ekstresi oral olarak 500 ml su içinde verildi. Müdahale 30 gün boyunca günlük olarak uygulandı.
Jackfruit Supplement
Participants in the experimental group will receive a daily dose of jackfruit supplement during the study period. The supplement is administered orally and standardized for bioactive components. Participants in the control group will not receive any jackfruit supplement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Jackfruit Supplement
Participants in the experimental group will receive a daily dose of jackfruit supplement during the study period. The supplement is administered orally and standardized for bioactive components. Participants in the control group will not receive any jackfruit supplement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy individuals without any diagnosed chronic disease
* Participating in regular weekly boxing training
* Able to continue training throughout the study period
* Willing to voluntarily participate in the study
* Able to provide written and/or verbal informed consent
Exclusion Criteria
* Any injury or musculoskeletal condition preventing continuation of training
* Known allergy or hypersensitivity to jackfruit or its components
* Use of medications or supplements that could interfere with study outcomes
* Individuals who refuse to provide informed consent
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bayburt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
HATİCE BUDAK
Researcher / Principal Investigator/ Master's Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
BÜLENT BAYRAKTAR
Role: PRINCIPAL_INVESTIGATOR
BAYBURT ÜNİVERSİTESİ
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bayburt Gençlik Merkezi Kapali Spor Salonu
Bayburt, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
This study investigates the effects of jackfruit consumption on adipokine levels (irisin, omentin-1), brain-derived neurotrophic factor (BDNF), cognitive performance, and anthropometric parameters in young boxers aged 18-25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BU-2025-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.